Jinhe Biology Technology Co., Ltd. announced the revised draft plan for issuing A-shares to specific objects by simplified procedures. The plan was approved at the fourth meeting of the seventh board of directors. The disclosure does not represent approval; the issuance requires further review and approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission. Investors are advised to be aware of investment risks.
Summary generated by AI · Always verify with source document
Securities Code: 002688
Securities Abbreviation: Jinhe Biology
Announcement No.: 2026-061
Jinhe Biology Technology Co., Ltd.
Announcement on Disclosure of the Revised Draft Plan for Issuing A-shares to Specific Objects by Simplified Procedures in 2025
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.